We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$85.1M
PA
2
Perceptive Advisors
New York
$78.6M
RI
3
RTW Investments
New York
$77.4M
CA
4
CHI Advisors
New York
$67.9M +$237K +10,050 +0.4%
7IH
5
72 Investment Holdings
Connecticut
$43.8M
CAM
6
Cormorant Asset Management
Massachusetts
$43.8M
BlackRock
7
BlackRock
New York
$22.3M +$22.2K +942 +0.1%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$17.5M -$654K -27,700 -4%
RSCM
9
Rock Springs Capital Management
Maryland
$14.5M +$331K +14,040 +2%
Franklin Resources
10
Franklin Resources
California
$13.2M
Vanguard Group
11
Vanguard Group
Pennsylvania
$12.9M +$83.7K +3,548 +0.7%
PIM
12
Platinum Investment Management
Australia
$11.9M +$3.48M +147,619 +42%
SCM
13
Suvretta Capital Management
New York
$11.4M -$3.43M -145,145 -23%
Norges Bank
14
Norges Bank
Norway
$9.29M
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$8.23M -$653K -27,685 -7%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$7.14M -$2.63M -111,600 -27%
O
17
OrbiMed
New York
$5.93M
Geode Capital Management
18
Geode Capital Management
Massachusetts
$5.1M +$108K +4,562 +2%
WP
19
Woodline Partners
California
$4.92M +$115K +4,855 +2%
HA
20
HHLR Advisors
Cayman Islands
$4.74M
OCA
21
Octagon Capital Advisors
New York
$4.74M
State Street
22
State Street
Massachusetts
$4.68M +$979K +41,465 +27%
Goldman Sachs
23
Goldman Sachs
New York
$4.02M +$4.01M +169,734 New
LCM
24
Laurion Capital Management
New York
$4M +$2.52M +106,714 +172%
Northern Trust
25
Northern Trust
Illinois
$2.4M -$229K -9,712 -9%